TNFRSF10B and lung carcinoma: Increasing evidence indicated that many cancer types including breast cancer cells, lung cancer cells, and hepatoma cells, could develop resistance to TRAIL-induced apoptosis through DR5-mediated activation of NF-κB signal pathway [24]–[26].